OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
Alejandro Pascual‐Iglesias, Javier Cantón, Ana María Ortega-Prieto, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1030-1030
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62

Human Monkeypox: A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies
Diana Fernández, David Fernández-Quezada, Fidel Casillas-Muñoz, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 947-947
Open Access | Times Cited: 32

Decoding SARS‐CoV‐2 Inhibition: Insights From Molecular Dynamics Simulation of Condensed Amino Thiourea Scaffold Small Molecules
Xiaoli Shen, Hao Zhang, Pengyin Zhang, et al.
Journal of Cellular Biochemistry (2025) Vol. 126, Iss. 2
Closed Access

Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets
Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, et al.
Biochemical Journal (2023) Vol. 480, Iss. 11, pp. 791-813
Open Access | Times Cited: 14

Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects
Rima Hajjo, Dima A. Sabbah, Alexander Tropsha
Pathogens (2022) Vol. 11, Iss. 7, pp. 743-743
Open Access | Times Cited: 16

pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity
Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, et al.
Journal of Biological Chemistry (2022) Vol. 299, Iss. 2, pp. 102790-102790
Open Access | Times Cited: 16

An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine
Mari Okada, Eriko Kikuchi, Masayuki Nagasawa, et al.
CEN Case Reports (2022) Vol. 11, Iss. 3, pp. 376-379
Open Access | Times Cited: 14

Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals
Yin‐Sui Xu, Jia‐Zhu Chigan, Jiaqi Li, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105799-105799
Open Access | Times Cited: 14

Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database
Jee‐Eun Kim, Jin Park, Young Gi Min, et al.
Journal of the Peripheral Nervous System (2022) Vol. 27, Iss. 3, pp. 206-214
Open Access | Times Cited: 14

What Happens to the Immune System after Vaccination or Recovery from COVID-19?
Bruna Tiaki Tiyo, G. Schmitz, Marina Mazzilli Ortega, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1152-1152
Open Access | Times Cited: 18

Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
Marta Sisteré‐Oró, Naína Andrade, Diana D. J. Wortmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13

Interferon-stimulated genes and their antiviral activity against SARS-CoV-2
Ana María Ortega-Prieto, Jose M. Jimenez-­Guardeño
mBio (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2

High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study
Klaus Hirschbühl, Tina Schaller, Bruno Märkl, et al.
Modern Pathology (2022) Vol. 35, Iss. 8, pp. 1013-1021
Open Access | Times Cited: 9

A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database
Jee‐Eun Kim, Jin Park, Tae‐Jin Song
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 13, pp. 2112-2123
Closed Access | Times Cited: 9

COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review
Shakiba Hassanzadeh, Addi Suleiman, Joaquim J Correia, et al.
Infezioni in Medicina (2024) Vol. 32, Iss. 1
Open Access | Times Cited: 1

The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region
Azmi Mahafzah, Malik Sallam, Faris G. Bakri, et al.
Advances in experimental medicine and biology (2024), pp. 299-322
Closed Access | Times Cited: 1

An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population
Dolores Adriana Ayón‐Núñez, Jacquelynne Cervantes‐Torres, Carlos Cabello-Gutiérrez, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1629-1629
Open Access | Times Cited: 6

Nursing and its Essential Role in the Vaccination against COVID-19: New Challenge in a Pandemic Scenario
R. Mauricio Barría
Investigación y Educación en Enfermería (2021) Vol. 39, Iss. 3
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top